title: Innervation of the human middle meningeal artery: immunohistochemistry, ultrastructure, and role of endothelium for vasomotility.
abstract: The majority of nerve fibers in the middle meningeal artery and branching arterioles are sympathetic, storing norepinephrine and neuropeptide Y (NPY). A sparse supply of fibers contain acetylcholinesterase activity and immunoreactivity toward vasoactive intestinal peptide (VIP), peptidine histidine methionine (PHM), and calcitonin gene-related peptide (CGRP). Only few substance P and neuropeptide K immunoreactive fibers are noted. Electronmicroscopy shows axons and terminals at the adventitial medial border of the human middle meningeal artery, with a fairly large distance to the smooth muscle cells (>500 nM). Several axon profiles contain vesicles of different types, including putative sensory profiles. The perivascularly stored signal substances, norepinephrine and NPY induced vasoconstrictor. Relaxations were induced by acetylcholine and substance P, and these were significantly reduced in arteries without endothelium, while the responses to norepinephrine, NPY, VIP, PHM, and CGRP were not changed by endothelium removal. Blockade experiments showed that the vasomotor responses to norepinephrine were blocked by prazosin, to NPY by BIBP 3226, acetylcholine by atropin, substance P by RP 67580, and the human alpha-CGRP response by human alpha-CGRP(8-37).
authors.affiliation: Department of Internal Medicine, University Hospital of Lund, Sweden. lars.edvinsson@med.lu.se
authors.forename: L
authors.initials: L
authors.lastname: Edvinsson
authors.forename: S
authors.initials: S
authors.lastname: Gulbenkian
authors.forename: C P
authors.initials: CP
authors.lastname: Barroso
authors.forename: M
authors.initials: M
authors.lastname: Cunha e Sá
authors.forename: J M
authors.initials: JM
authors.lastname: Polak
authors.forename: A
authors.initials: A
authors.lastname: Mortensen
authors.forename: L
authors.initials: L
authors.lastname: Jørgensen
authors.forename: I
authors.initials: I
authors.lastname: Jansen-Olesen
mesh_terms: D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000110:Acetylcholinesterase / Q000032:analysis; D015740:Calcitonin Gene-Related Peptide / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology; D015237:Dinoprost / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D066298:In Vitro Techniques; D008576:Meningeal Arteries / Q000737:chemistry / Q000294:innervation* / Q000648:ultrastructure; D008854:Microscopy, Electron; D009412:Nerve Fibers / Q000737:chemistry* / Q000648:ultrastructure; D009478:Neuropeptide Y / Q000032:analysis / Q000037:antagonists & inhibitors / Q000494:pharmacology; D009479:Neuropeptides / Q000032:analysis; D019001:Nitric Oxide Synthase / Q000032:analysis; D052250:Nitric Oxide Synthase Type III; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D010451:Peptide PHI / Q000494:pharmacology; D013373:Substance P / Q000032:analysis / Q000037:antagonists & inhibitors; D015320:Tachykinins; D014446:Tyrosine 3-Monooxygenase / Q000032:analysis; D014660:Vasoactive Intestinal Peptide / Q000032:analysis / Q000494:pharmacology; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
chemical_list: D009478:Neuropeptide Y; D009479:Neuropeptides; D010451:Peptide PHI; D015320:Tachykinins; C045206:neuropeptide K; D013373:Substance P; D014660:Vasoactive Intestinal Peptide; D015237:Dinoprost; C496314:NOS3 protein, human; D019001:Nitric Oxide Synthase; D052250:Nitric Oxide Synthase Type III; D014446:Tyrosine 3-Monooxygenase; D000110:Acetylcholinesterase; D015740:Calcitonin Gene-Related Peptide; D000109:Acetylcholine; D009638:Norepinephrine